v3.25.1
STOCKHOLDERS’ EQUITY
 3 Months Ended
Mar. 28, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY STOCKHOLDERS’ EQUITY
Share-based Compensation Plans
The following table sets forth the detailed allocation of the share-based compensation expense which was included in the Company’s condensed consolidated statements of operations:
 Three Months Ended
(in thousands)March 28, 2025March 29, 2024
Cost of revenue$562 $523 
Research and development2,492 1,955 
Selling, general and administrative5,411 4,445 
Total$8,465 $6,923 
Restricted Stock Units:
(in thousands, except per share amounts)Number
of
Shares		Weighted Average
Grant-Date Fair Value
Per Share
Balance at December 31, 20243,447 $12.95 
Granted1,148 8.77
Vested(1,372)12.32
Forfeited(83)13.11
Balance at March 28, 20253,140 $11.69 
The Company’s stock benefit plans include the 2002 Employee Stock Purchase Plan (as amended and restated, the “ESPP”) and current active stock plans adopted in 1995 and 2002 (as amended and restated, the “1995 Stock Plan” and “2002 Director Plan”, respectively). Refer to Note 11, “Employee Benefit Plans” of Notes to Consolidated Financial Statements in the 2024 Form 10-K for details pertaining to each plan.
As of March 28, 2025, an aggregate of 10,153,234 shares of common stock were reserved for issuance under the 1995 Stock Plan, of which 6,753,629 shares remained available for future grants. As of March 28, 2025, an aggregate of 278,979 shares of common stock were reserved for issuance under the 2002 Director Plan.
Share Repurchase Program
In February 2025, the Board of Directors terminated the Company’s existing stock repurchase program and authorized a new program under which the Company may repurchase up to $200 million of its outstanding shares of common stock through February 2028. The Company is authorized to repurchase, from time-to-time, shares of its outstanding common stock through open market purchases and 10b5-1 trading plans, in accordance with applicable rules and regulations, at such time and such prices as management may decide. The program does not obligate the Company to repurchase any specific number of shares and may be discontinued at any time. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors.
During the three months ended March 28, 2025, the Company repurchased and retired approximately 3.5 million shares of the Company’s common stock for an aggregate amount of $36.1 million. As of March 28, 2025, approximately $163.9 million of the share repurchase authorization remained available for repurchases under this program.